Balchem Corp (BCPC) Stock Price & Analysis
Balchem Corp (BCPC) rose 2.29% to USD 162.32 as of June 10, 2026 at 00:57 UTC, according to Nexqual real-time market data.
BCPC last closed at USD 158.69; the session ranged USD 159.9–162.66 on volume of 186,563 shares. Market capitalization is $5.22B, with a 52-week range of USD 139.17–183.9 (NMS). Source: Nexqual, June 10, 2026 at 00:57 UTC.
Key Statistics (as of June 10, 2026 at 00:57 UTC)
| Price | USD 162.32 |
|---|---|
| Change | ▲ 2.29% (up) |
| Previous Close | USD 158.69 |
| Open | USD 159.9 |
| Day Range | USD 159.9 – 162.66 |
| 52-Week Range | USD 139.17 – 183.9 |
| Volume | 186,563 shares |
| Market Cap | $5.22B |
| Exchange | NMS |
Technical Analysis (BCPC)
Nexqual's technical model rates BCPC "SELL" based on 2 bullish and 4 bearish signals across 124 daily candles, as of June 10, 2026 at 00:57 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 48.34 (neutral) |
| vs SMA50 | Below (USD 166.17) |
| MACD | -1.7 (negative) |
Analyst Ratings (BCPC)
Wall Street analysts rate BCPC "None" based on 4 analysts, with a mean price target of USD 200.75 (range USD 164–234), per Nexqual as of June 10, 2026 at 00:57 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 4 |
| Mean Target | USD 200.75 |
| High Target | USD 234 |
| Low Target | USD 164 |
| Buy / Hold / Sell | 2 / 1 / 0 |
Earnings (BCPC)
| Next Earnings Date | 2026-07-30 |
|---|---|
| EPS Estimate | USD 1.43 |
| Revenue Estimate | $268.50M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD 1.33 vs est 1.33 ▲ beat |
| 2025-12-31 | USD 1.31 vs est 1.29 ▲ beat |
| 2025-09-30 | USD 1.35 vs est 1.31 ▲ beat |
| 2025-06-30 | USD 1.27 vs est 1.25 ▲ beat |
Source: Nexqual, June 10, 2026 at 00:57 UTC.
Financials & Fundamentals (BCPC)
| Total Revenue | $1.06B |
|---|---|
| Revenue Growth (YoY) | +8.10% |
| Gross Margin | +36.28% |
| Operating Margin | +20.88% |
| Profit Margin | +14.95% |
| ROE | +12.68% |
| Debt / Equity | 14.37 |
| Current Ratio | 2.55 |
| Total Cash | $72.87M |
| Total Debt | $184.71M |
| Free Cash Flow | $138.14M |
Source: Nexqual, June 10, 2026 at 00:57 UTC.
Financial Health Score (BCPC)
Nexqual rates Balchem Corp's overall financial health "Solid" across five dimensions, as of June 10, 2026 at 00:57 UTC.
| Growth | Solid — Revenue +9% YoY (annual) |
|---|---|
| Profitability | Solid — Gross margin 36%, operating 21% |
| Balance Sheet | Strong — $73M cash vs $185M debt |
| Cash Flow | Solid — FCF $138M, 13% margin |
| Efficiency | Mixed — ROE 13%, ROA 8.1% |
Ownership (BCPC)
| Insider Ownership | +0.47% |
|---|---|
| Institutional Ownership | +93.64% |
| Shares Outstanding | 32.13M |
| Float | 31.95M |
| Short % of Float | +1.59% |
Source: Nexqual, June 10, 2026 at 00:57 UTC.
Leadership (BCPC)
Balchem Corp is led by Theodore Lee Harris (age 60), CEO, President & Chairman, per Nexqual as of June 10, 2026 at 00:57 UTC.
| CEO, President & Chairman | Theodore Lee Harris (age 60) |
|---|---|
| Executive VP, CFO, Treasurer and GM of Animal Nutrition & Health | Carl Martin Bengtsson (age 48) |
Major Backers & Investors (BCPC)
Notable institutional backers of Balchem Corp include Wasatch Advisors LP, Conestoga Capital Advisors, LLC, Morgan Stanley, according to Nexqual as of June 10, 2026 at 00:57 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Wasatch Advisors LP | 4.43% |
| Conestoga Capital Advisors, LLC | 3.89% |
| Morgan Stanley | 2.67% |
| Geneva Capital Management LLC | 2.63% |
| FMR, LLC | 1.86% |
| Conestoga Funds-Conestoga Small Cap Fund | 1.76% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 23.6% |
| Vanguard Group | 19.16% |
| State Street | 3.86% |
| Geode Capital | 3.26% |
Source: Nexqual, June 10, 2026 at 00:57 UTC.
From Balchem Corp's Latest SEC 10-K Filing (filed 2026-02-20)
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| IOSP | Innospec Inc. | USD 82.83 | ▲ 2.66% |
| KWR | Quaker Houghton | USD 142.94 | ▲ 1.6% |
| DORM | Dorman Products, Inc. | USD 127.98 | ▲ 0.75% |
| SXT | Sensient Technologies Corporati | USD 119.47 | ▲ 6.49% |
| EXPO | Exponent, Inc. | USD 57.23 | ▼ 4.07% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 00:57 UTC. This page is informational and not investment advice.